PharmaCyte Biotech, Inc.

NASDAQ:PMCB

1.56 (USD) • At close December 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Assets:
Current Assets:
Cash & Cash Equivalents 50.1868.0485.4012.2020.8950.5151.063.4641.9212.73.6160.1990.0160.0570.0010.6041.5141.1091.0690.0380.08400
Short Term Investments 0000000000000000.0310000.166000
Cash and Short Term Investments 50.1868.0485.4012.2020.8950.5151.063.4641.9212.73.6160.1990.0160.0570.0010.6351.5141.1091.0690.2040.08400
Net Receivables 0000000000000.0030.0020.010.2160.490.23100.002000
Inventory 0000000000000.0070.0190.0030.1170.2432.03400.0070.04700
Other Current Assets 0.260.2150.1880.1460.2860.2760.4480.1490.221.4680.573.171.0340.02700.2141.4892.0932.060.007000
Total Current Assets 50.4468.14885.4952.2751.0380.6531.2843.5392.0312.8194.1871.8481.0590.1050.0141.1833.7353.4333.1290.2440.13100
Non-Current Assets:
Property, Plant & Equipment, Net 00000000000000.0540.1082.6440.0230.0080.0070.0920.04500
Goodwill 0000000000000002.1130000000
Intangible Assets 1.5493.5493.5493.5493.5493.5493.5493.5493.5493.5493.54900000.8570.8630.86400000
Goodwill and Intangible Assets 1.5493.5493.5493.5493.5493.5493.5493.5493.5493.5493.54900002.970.8630.86400000
Long Term Investments 01.5721.5721.5721.5721.5721.5721.5721.5721.5721.572000000000000
Tax Assets 00000000000000000000000
Other Non-Current Assets 7.9150.0080.0080.0070.0070.0070.0070.0070.0080.0080.0081.0291.0291.0811.0810.0452.9940.120000
Total Non-Current Assets 9.4645.1295.1295.1295.1295.1295.1295.1295.1295.1295.1291.0291.0291.1351.1895.6593.8810.9722.0070.0920.04500
Total Assets 59.90473.27790.6247.4046.1675.7826.4138.6677.167.9489.3162.8772.0881.241.2026.8427.6164.4055.1360.3360.17600
Liabilities & Equity:
Current Liabilities:
Account Payables 0.3890.1280.2050.1720.1860.1220.3530.3660.3360.4970.1880.3520.730.7060.6750.210.1440.0990.0760.25800.0030
Short Term Debt 0000.0510.0290000000.422.0922.3722.2830.4850000000
Tax Payables 0.340.058000000000000000000000
Deferred Revenue 000-0.051000000-00.68500000.008000000
Other Current Liabilities 6.6920.40.4990.5020.8170.6210.2920.2150.3021.0240.1863.0260.9650.3120.0960.2230.0290.020.030.04000
Total Current Liabilities 7.4210.5870.7040.7251.0310.7430.6440.580.6382.0120.3743.7983.7873.3893.0530.9190.1810.1190.1060.29700.0030.01
Non-Current Liabilities:
Long Term Debt 00000.0460000000000.11.93000.5081.2780.32500
Deferred Revenue Non-Current 00000000000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000000000
Other Non-Current Liabilities 12.9680000000000000.5800.004000.110.0560.00400
Total Non-Current Liabilities 12.96800.20500.0460.1220000000.580.580.11.934000.6181.3340.32900
Total Liabilities 20.3890.5870.7040.7251.0780.7430.6440.580.6382.0120.3743.7984.3673.9693.1532.8520.1810.1190.7241.6310.3290.0030.01
Equity:
Preferred Stock 11.86700000000000.580.580.580.500000000
Common Stock 0.0020.0020.00200.1640.1190.1010.0910.0780.0730.0690.0480.0420.0360.0350.0250.0190.0160.0180.0110.0090.0150.015
Retained Earnings -115.625-115.959-111.649-107.409-103.858-100.031-95.964-89.135-84.692-79.555-68.7-41.446-39.848-37.949-36.551-29.492-23.45-19.658-16.044-6.659-2.37-0.646-0.614
Accumulated Other Comprehensive Income/Loss -0.024-0.023-0.016-0.02-0.022-0.014-0.0050.0020.0010.0010.002-0.024-0.024-0.1660-0.031-0.0080.003-00000
Other Total Stockholders Equity 143.294188.67201.582114.109108.805104.966101.63697.1391.13586.3375.99939.89637.5534.60434.06533.44830.86723.92620.4385.3522.2080.6340.591
Total Shareholders Equity 39.51572.6989.926.6795.0895.045.7698.0876.5235.9368.942-0.921-2.28-2.729-1.9513.997.4364.2864.412-1.295-0.153-0.003-0.008
Total Equity 39.51572.6989.926.6795.0895.045.7698.0876.5235.9368.942-0.921-2.28-2.729-1.9513.997.4364.2864.412-1.295-0.153-0.003-0.008
Total Liabilities & Shareholders Equity 59.90473.27790.6247.4046.1675.7826.4138.6677.167.9489.3162.8772.0881.241.2026.8427.6164.4055.1360.3360.17600